Mereo BioPharma Group plc

NASDAQ:MREO

Biotechnology

Healthcare
$0.32 +9.69%

+$0.03 today

Market cap
$51.08M
Beta
0.28
P/E (TTM)
-1.4
EPS (TTM)
-$0.22
52W Low $0.20High $3.05

Volume 1.26M

Average 3.36M

Balance Sheet

Inspect the capital base behind the business.

Assets

$45.92M

FY 2025 · Annual

-39.9% YoY

Liabilities

$5.00M

FY 2025 · Annual

-67.6% YoY

Equity

$40.92M

FY 2025 · Annual

-32.9% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents126.75M68.18M57.42M69.8M40.99M
Short-term Investments769.47K0000
Net Receivables003.73M3.25M1.98M
Inventory00000
Other Current Assets3.01M3.23M1.98M507K141K
Total Current Assets134.32M75.2M63.76M74.76M45.02M
Property, Plant & Equipment (Net)3.42M2.22M1.65M984K381K
Goodwill00000
Intangible Assets33.22M29.01M1.09M643K516K
Long-term Investments00000
Tax Assets00000
Other Non-current Assets10000
Total Non-current Assets36.64M2.22M2.74M1.63M897K
Total Assets170.96M77.41M66.5M76.39M45.92M
Account Payables3.09M3.49M2.35M2.44M1.33M
Short-term Debt013.33M05.54M0
Tax Payables00662K770K0
Deferred Revenue00000
Other Current Liabilities7.6M1.36M2.37M(413K)1M
Total Current Liabilities16.96M24.38M9.49M13.85M4.3M
Long-term Debt19.45M04.39M00
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities13.17M157K1.18M1.39M699K
Total Non-current Liabilities34.99M1.64M6.48M1.57M699K
Total Liabilities51.95M26.01M15.96M15.42M5M
Common Stock2.37M2.48M2.78M3.06M3.14M
Retained Earnings(401.6M)(404.58M)(419.63M)(462.88M)(501.02M)
Accumulated OCI183.58M(21.69M)(17.49M)(18.85M)(10.82M)
Other Stockholders Equity10000
Minority Interest00000
Total Equity119.01M51.4M50.54M60.97M40.92M
Total Debt22.66M15.37M5.95M6.43M202K
Net Debt(104.08M)(52.81M)(51.47M)(63.37M)(40.79M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$36.2M
Receivables$1.9M
Other Current$1.9M
Total Current Assets$40.0M
PP&E (Net)$199.0K
Intangible Assets$381.0K
Total Non-current Assets$580.0K
Total Assets$40.6M

Analysis

Selected assets total $40.6M for Latest. The largest visible component is Cash & Equivalents at $36.2M, about 89.2% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportAug 19, 2026
SC 13G/ASC 13G/A filingAug 14, 2026
10-QQuarterly reportAug 11, 2026
8-KCurrent reportAug 11, 2026
8-KCurrent reportAug 11, 2026

How much cash does MREO have?

Mereo BioPharma Group plc (MREO) reported $40.99M in cash and equivalents in fiscal 2025.

How much debt does MREO carry?

Mereo BioPharma Group plc (MREO) reported $202,000.00 of total debt, with net debt of -$40.79M.